Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Brown, MD
MD Anderson Cancer Center, Houston TX USA
Principal Investigator - Vinai Gondi, MD
Northwestern Medicine Cancer Center, Warenville IL USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medizinische Universität Innsbruck
Innsbruck, Austria
- Umhat Sv. Ivan Rilski Ead, Department of Medical Oncology
Sofia, Bulgaria
- University Multiprofile Hospital for Active Treatment Sofiamed, Department of Medical Oncology
Sofia, Bulgaria
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Centre Hospitalier de L'Universite de Montreal (chum)
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Le Ciusss de I'Est-de-L'Ile de Montreal - Hôpital Maisonneuve Rosemont
Montreal, Quebec, Canada
- (chus) Centre Hospitalier Universitaire de Sherbrooke, Service de Neurochirurgie
Sherbrooke, Quebec, Canada
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Chaoyang, China
- the First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China
- Hubei Cancer Hospital
Wuhan, Hubei, China
- Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
- Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
- the First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
- Northern Jiangsu People'S Hospital
Yangzhou, Jiangsu, China
- Liaoning Cancer Hospital
Shenyang, Liaoning, China
- First Affiliated Hospital of Xi'An Jiaotong University
Xi'an, Shaanxi, China
- Qilu Hospital of Shandong University
Jinan, Shandong, China
- Shandong Cancer Hospital
Jinan, Shandong, China
- Qingdao Central Hospital
Qingdao, Shandong, China
- Zigong Fourth People'S Hospital
Zigong, Sichuan, China
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
- Fudan University Shanghai Cancer Center
Shanghai, Xuhui District, China
- Taizhou Hospital, Zhejiang Province
Zhejiang, Zhejiang, China
- Peking University Third Hospital
Beijing, China
- the First Hospital of Jilin University
Changchun, China
- the Second Affiliated Hospital of Xingtai Medical College
Hebei, China
- the First Hospital of China Medical University
Shenyang, China
- the University of Hong Kong-Shenzhen Hospital
Shenzhen, China
- the First Affiliated Hospital of Xiamen University
Xiamen, China
- Radiochirugia Zagreb
Sveta Nedelja, Croatia
- University Hospital Lille
Lille, France
- Clairval Hospital Center
Marseille, France
- Hopital Pitié-Salpétriere
Paris, France
- Centre Hospitalier Universitaire de Saint-Étienne
Saint-Etienne, France
- Klinik Für Radioonkologie Und Strahlentherapie Der Charité Universitätsmedizin Berlin Campus Charité Virchow-Klinikum
Berlin, Germany
- Universitätsklinikum Düsseldorf
Düsseldorf, Germany
- Dr. Senckenbergisches Institut for Neurooncology,
Frankfurt am Main, Germany
- Dr. Senckenbergisches Institut Für Neuroonkologie, Zentrum Der Neurologie Und Neurochirurgie
Frankfurt am Main, Germany
- Universitätsklinikum Halle (saale), Klinik Für Innere Medizin Iv, Hämatologie / Onkologie
Halle, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2016
- Primary completion
- 29 Nov 2024
- Completion
- 29 Nov 2024
- Last update posted
- 31 Oct 2025
- Registered enrollment
- 298
- Registry id
- NCT02831959
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.